HR-2161-119
Referred to the House Committee on the Judiciary.
Sponsored by Christopher Smith (R-NJ)
What it does
This bill would make it a federal crime to knowingly create, transfer, transport, or receive certain human-animal "chimeras" — organisms combining human and animal genetic material in specific ways defined in the bill, such as embryos with mixed human-animal chromosomes or animals engineered with human brain tissue or human facial features. Violations would carry up to 10 years in prison, fines, and a civil penalty of at least $1 million or twice any financial gain from the violation. The bill explicitly does not prohibit standard research using transgenic animals with inserted human genes or transplanting human tissue into animals.
Who benefits
Groups holding ethical or religious objections to blending human and animal genetic material, who would see a categorical federal ban on practices they view as morally impermissible; researchers who avoid this narrow category and thus face no new burden, potentially gaining clearer legal boundaries around permissible transgenic and xenotransplantation work.
Who is hurt
Biomedical researchers working on organ-transplant models, neurological disease models, or other chimera-based research that could fall within the bill's broad definitions (such as those involving human neural tissue in animals), who could face prosecution or a chilling effect on legitimate scientific work; universities and biotech companies funding such research, which may face uncertainty over which experiments are legal; patients who might eventually benefit from chimera-based advances such as lab-grown organs for transplantation, who could see delayed research progress.
Supporters argue
Supporters argue that creating organisms blurring the line between human and animal raises profound ethical concerns, particularly regarding human dignity and the moral status of any entity with human neural or reproductive characteristics. They contend that clear federal criminal boundaries are necessary to prevent morally fraught experiments — such as animals with predominantly human brains or human gametes developing inside animal bodies — before such research becomes technically feasible and difficult to reverse.
Opponents argue
Opponents argue the bill's broad and technical definitions could criminalize legitimate biomedical research, such as growing human organs in animals for transplantation or studying neurological diseases using humanized animal models, potentially subjecting scientists to a decade in prison for good-faith research. They contend that despite the research carve-out, the vague thresholds for "predominantly human" neural tissue or facial resemblance create legal uncertainty that could chill valuable science without a clear, evidence-based line between acceptable and prohibited work.
Constitutional context
Congress relies on its Commerce Clause authority to criminalize activity "in or affecting interstate commerce," a common basis for federal criminal statutes since United States v. Lopez (1995) required some jurisdictional nexus to interstate commerce for such laws to survive. The bill does not raise a clearly established individual-rights issue, though vague or overbroad definitions could theoretically invite a Fifth Amendment due process vagueness challenge.
Checks and balances
Congress would create a new federal crime enforced by federal prosecutors (executive branch), with courts serving as the check by interpreting the statute's definitions and reviewing any vagueness or overbreadth challenges.
Historical precedent
No prior federal statute has specifically banned human-animal chimera creation, though some states have enacted similar prohibitions and Congress has debated comparable bills in past sessions without enactment.